Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

NHS Digital has published statistics on vaginal mesh procedures

21 May 2018

The report “Retrospective Review of Surgery for Urogynaecological Prolapse and Stress Urinary Incontinence using Tape or Mesh: Hospital Episode Statistics (HES), Experimental Statistics, April 2008 - March 2017” has been produced by NHS Digital, to investigate activity, summarised within Hospital Episode Statistics (HES) data, for the NHS, in England, of patients who have had a urogynaecological procedure for the treatment of urogynaecological prolapse or stress urinary incontinence, including those where mesh, tape or their equivalents have been used. The HES data warehouse contains details of all admissions, outpatient appointments and accident and emergency (A&E) attendances at NHS hospitals in England. This report covers the period from April 2008 to March 2017, using Admitted Patient Care and Outpatient data.

Key findings in the report include:

  • Between 2008/09 and 2016/17, 100,516 patients had a reported tape insertion procedure for stress urinary incontinence and 27,016 patients had a reported mesh insertion procedure for urogynaecological prolapse.
  • In 2016/17 there were 7,245 patients who had an insertion for this procedure and 2,680 patients who had an insertion for this procedure, which is a reduction of 48 and 13 per cent, respectively, from 2008/09.
  • For patients who had a removal procedure more than 30 days after their initial insertion, the highest rate of readmissions occurs in the reporting year following the insertion.

See full details here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.